3.2 GLP-1RAs in psoriatic arthritis The therapeutic landscape of PsA is currently dominated by targeted agents that inhibit key inflammatory pathways, including TNF inhibitors (e.g., adalimumab, etanercept), IL17 inhibitors (e.g., secukinumab, ixekizumab), IL-23 inhibitors (e.g., guselkumab, risankizumab), and Janus kinase (JAK) inhibitors such as upadacitinib and tofacitinib (62)
Any decision to use lipotropic injections alongside tirzepatide should involve informed discussion about the absence of safety data and the unregulated nature of compounded products
Understanding Semaglutide Injection While originally intended for type 2 diabetes treatment, semaglutide has been shown to have weight loss benefits in recent studies
Whether your goal is overall wellness, antioxidant support or skin lightening, taking an insufficient dosage may limit the benefits experienced